ArticleCellular oncology (Dordrecht, Netherlands)2025

Next-generation BCMA-targeted chimeric antigen receptor CARTemis-1: the impact of manufacturing procedure on CAR T-cell features.

Belén Sierro-Martínez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.